IMPROVED CYSTEINE-BASED PRODRUGS USEFUL IN THE TREATMENT OF SCHIZOPHRENIA

摘要

The invention relates to propionic acids, propionic acid esters, and related compounds, pharmaceutical compositions containing these compounds, and methods of using these compounds for the treatment of various diseases or conditions, including but not limited to diseases and/or conditions of Central Nervous System (CNS).